Gilde Healthcare buys Europin

The GP bought Acti-Med less than 12 months ago. It said the merger creates one of the largest contract manufacturers of raw cannulas and cannula systems in Europe. 

Gilde partner Rafael Natanek told Mergermarket last year that it would target specialist cannula manufacturers operating in the ready-for-cleanroom (R4C) or ready-for-market (R4M) segments but was focusing on organic growth.

It bought Acti-Med from its EUR 200m 2019-vintage Gilde Healthcare Services III fund.

An unidentified investment company based in Germany took a majority stake in Europin in 2019 from the founding family, according to a statement from DZ Bank that said it acted as advisors. 

The company 

Europin is a manufacturer of pen cannulas, lancet needles and special purpose needles for the medical and pharmaceutical world market with a particular focus on injection systems for self-medication in the field of diabetes and hormone therapies. It produces more than two million needs and cannulas a year. 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• CEE
• Buyouts
• Healthcare
• Gilde Buy Out Partners
• healthcare